Provisions in the Act can be used to provide for compulsory licensing. This will allow the centre, without the permission of the patentee, to use a vaccine for a national emergency at affordable prices.
A petition has been filed in the Supreme Court, seeking directions to the Central government to make public the segregated data of clinical trials for the vaccines that are being administered to the population in India under the Emergency Use Authorisation.